CIDP treatment focuses on reducing and slowing the immune processes damaging your peripheral nervous system. It includes corticosteroids, intravenous immunoglobulin, and plasma exchange ...

GBS, also known as classic or ascending paralysis, begins in the lower limbs and is technically called Acute Inflammatory ...

Immunovant anticipates initiating clinical trials evaluating IMVT-1402 in a total of ten indications by March 31, 2026. Neurology Program: ...

Reports Q3 revenue $9.02M, consensus $4.75M. “Roivant has broadened our clinical pipeline with the newly announced trial of brepocitinib in ...

Immunovant stock down on dismal third-quarter fiscal 2025 results. It is on track to initiate 10 studies on IMVT-1402 across various autoimmune indications.

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

Stephanie Lee Griffin; Chief Operating Officer; Roivant Sciences Ltd. Matt Gline; Chief Executive Officer, Director; Roivant Sciences Ltd. Dave Risinger; Analyst; Le ...

A 64-year-old woman in Mumbai has been diagnosed with Guillain-Barre Syndrome, marking the city's first case of this rare nerve disorder. After being hospitalized with fever and ascending paralysis, ...

H.C. Wainwright reaffirmed their Buy rating on Immunovant (NASDAQ:IMVT) shares with a price target of $51.00, aligning with the broader Wall Street sentiment. According to InvestingPro data, analyst ...

MUMBAI: The tally of Guillain Barre Syndrome (GBS) cases in Maharashtra has reached 189, while the first GBS-suspected patient from Andheri-East was detect ...

Barré Syndrome (GBS), a rare nerve disorder, in a 64-year-old woman. The patient, who resides in Andheri east, was ...

Mumbai reported its first case of Guillain-Barre Syndrome (GBS) on Friday after a 64-year-old woman was diagnosed with the rare nerve disorder, civic officials said. GBS is a rare condition in which a ...